Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease Type/Condition

Age Group


Drug/Medication


162 results found

✔ Specialty: Cancer

Breast, Colon, Esophagus, Liver, Lung

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy

This study focuses on individuals who have been diagnosed with a Stage I-IV cancer that is being treated with high-dose radiotherapy with their heart in or near the treatment area. The purpose of the study ...


Lung

Bronchial Neuroendocrine Tumors: Lutetium Lu 177 Dotatate Versus Everolimus

This study focuses on individuals who have advanced bronchial neuroendocrine cancer and whose cancer has an increase in the expression of a receptor called the somatostatin receptor (SSTR). The purpose of the study is to ...


Cervix, Liver, Lung, Melanoma, Small Intestine, Stomach, Urinary Bladder

Bioatla, BA3071-001, Ph 1/2, Open-Label, MTD, MUC, NSCLC RP2D, adv solid tumors

Phase 1 Objectives 2.1.1. Primary Objective To define the safety profile, including DLT, and determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of BA3071 when delivered concomitantly with nivolumab, a programmed ...


Melanoma

Modakafusp Alfa (TAK-573) and Pembrolizumab in Advanced or Metastatic Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, and effectiveness of an investigational drug called modakafusp alfa in combination with pembrolizumab in patients with metastatic cutaneous melanoma that is unresectable (cannot be ...


Non-Hodgkin's Lymphoma

Diffuse Large B-Cell Lymphoma: Tafasitamab Plus Lenalidomide in Addition to R-CHOP

This study focuses on individuals who have been recently diagnosed with diffuse large B-cell lymphoma (DLBCL), a cancer of the blood system. Most patients with newly diagnosed DLBCL are treated with the standard therapy called ...